Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non-small-cell lung cancer in New Zealand.

Mark James McKeageSandar Tin TinPrashannata KhwaounjooKaren SheathAmanda Dixon-McIverDaniel NgRichard SullivanLaird CameronPhilip ShepherdGeorge R LakingNicola KingstonMagreet StraussChristopher A LewisMark ElwoodDonald R Love

Published in: Internal medicine journal (2021)

Lung cancer outcomes in New Zealand may be improved by providing national guidelines and funding policy for ALK testing and access to subsidised ALK TKI therapy.

Keyphrases

advanced non small cell lung cancer
tyrosine kinase
epidermal growth factor receptor
healthcare
public health
genome wide
copy number
protein kinase
type diabetes
mesenchymal stem cells
adipose tissue
bone marrow
genome wide analysis
smoking cessation